Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Pouillon

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Crohn'S & Colitis|October 30, 2024
Framework of IBD Care Delivery Across AgesStefan Delen, Susanna Jaghult, Irina Blumenstein, et al.
Gastroenterology|February 3, 2018
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!Francesca Jaboli, Lieven Pouillon, Peter Bossuyt, et al.
Expert Opinion on Biological Therapy|October 27, 2020
Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USARovshan M Ismailov, Lieven Pouillon, Christian P Selinger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 14, 2017
E-health in inflammatory bowel diseases: More challenges than opportunities?Peter Bossuyt, Lieven Pouillon, Guillaume Bonnaud, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2018
Effectiveness of golimumab in ulcerative colitis: A review of the real world evidencePablo Olivera, Silvio Danese, Lieven Pouillon, et al.
Nature Reviews. Gastroenterology & Hepatology|April 19, 2020
Head-to-head trials in inflammatory bowel disease: past, present and futureLieven Pouillon, Simon Travis, Peter Bossuyt, et al.
Best Practice & Research. Clinical Gastroenterology|August 1, 2018
Colorectal cancer prevention in patients with ulcerative colitisAnthony Lopez, Lieven Pouillon, Laurent Beaugerie, et al.
Nature Reviews. Gastroenterology & Hepatology|January 6, 2021
Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and futureLieven Pouillon, Simon Travis, Peter Bossuyt, et al.
Best Practice & Research. Clinical Gastroenterology|August 1, 2018
Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?Lieven Pouillon, Johan Van Stappen, Peter Bossuyt, et al.
Gut|January 15, 2018
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisationCélia Gouynou, Lieven Pouillon, Hélène Rousseau, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Crohn'S & Colitis|October 30, 2024
Framework of IBD Care Delivery Across AgesStefan Delen, Susanna Jaghult, Irina Blumenstein, et al.
Gastroenterology|February 3, 2018
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!Francesca Jaboli, Lieven Pouillon, Peter Bossuyt, et al.
Expert Opinion on Biological Therapy|October 27, 2020
Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USARovshan M Ismailov, Lieven Pouillon, Christian P Selinger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 14, 2017
E-health in inflammatory bowel diseases: More challenges than opportunities?Peter Bossuyt, Lieven Pouillon, Guillaume Bonnaud, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2018
Effectiveness of golimumab in ulcerative colitis: A review of the real world evidencePablo Olivera, Silvio Danese, Lieven Pouillon, et al.
Nature Reviews. Gastroenterology & Hepatology|April 19, 2020
Head-to-head trials in inflammatory bowel disease: past, present and futureLieven Pouillon, Simon Travis, Peter Bossuyt, et al.
Best Practice & Research. Clinical Gastroenterology|August 1, 2018
Colorectal cancer prevention in patients with ulcerative colitisAnthony Lopez, Lieven Pouillon, Laurent Beaugerie, et al.
Nature Reviews. Gastroenterology & Hepatology|January 6, 2021
Author Correction: Head-to-head trials in inflammatory bowel disease: past, present and futureLieven Pouillon, Simon Travis, Peter Bossuyt, et al.
Best Practice & Research. Clinical Gastroenterology|August 1, 2018
Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?Lieven Pouillon, Johan Van Stappen, Peter Bossuyt, et al.
Gut|January 15, 2018
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisationCélia Gouynou, Lieven Pouillon, Hélène Rousseau, et al.
Pageof 6